Article -> Article Details
Title | Valley Fever Market - Analysis, Size, Business Growth by 2023 |
---|---|
Category | Fitness Health --> Health Insurance |
Meta Keywords | Valley Fever Market |
Owner | vinit |
Description | |
Overview: The global market report containing various details of the valley
fever market predicted a substantial rise during the forecast period of 2018 to
2022. Market Research Future (MRFR) analyzed several factors as well to
understand the movement of the market and how certain trends can inspire the
market movement. The disease is also known as coccidioidomycosis, a type of
fungal infection. It is commonly found in soil and dust across the world.
However, it is more prevalent in the American region. Any type of activity like
construction and farming that triggers a disruption in soil structure can
release these bacteria into the air. People around those areas, if inhale the
same air, would contract the disease and it can be fatal. Government
initiatives to boost awareness related to the disease and increasing expenditure
to find a proper cure are expected to inspire market growth. Segmentation: The global understanding of the valley
fever market reveals segments like the site of infection and
treatments to understand the nuances of the market. This segmentation allows a
decent analysis of the changes in the market that has been backed by scientific
approaches, volumes and values, and aspects. By site of infection, the global market on the valley fever
has been segmented into liver, bones, skin, brain, heart, and membranes that
share a connection with the brain and spinal cord and others. By treatments, the understanding of the global valley fever
market has been segmented into itraconazole, posaconazole, voriconazole,
fluconazole, and others. Regional Analysis: The Americas would dominate the global market as the region
displays the maximum number of cases each year. Government initiatives,
availability of medicine, and others are expected to provide thrust to the
market. In addition, local awareness regarding the disease is high, which would
influence the market outcome. Competitive Landscape: Johnson and Johnson, Novartis, Anacor Pharmaceuticals,
Bristol Meyer Squibb, Valeant Pharmaceutical, Galderma S.A., Pfizer Inc.,
GlaxoSmithKline Pharmaceuticals Limited, and others are some of the prominent
names associated with the global valley fever market that can trigger better
growth during the forecast period. These companies are relying heavily on
strategic mechanisms like a merger, acquisition, innovation, research funding,
development of treatment, and others to ensure growth for themselves and for
the market. MRFR learned of its latest measures to understand how various
trends would inspire the market in the coming days. Industry News: In July 2020, the Chinese Consulate General in Los Angeles
issued a warning to the Chinese citizens residing in the southwest regions of
the United States, stating that they should learn more about Valley Fever, a
fungal infection. This awareness would help in take better preventive measures
and get treatment for the same. In Phoenix, the capital city of Arizona state,
three Chinese people had already contracted the disease and two of them died
from the disease. In July 2020, the Food and Agriculture Organization (FAO)
department of the United Nations (UN) donated protective gears worth around USD
5 million to the Ugandan government to fight rift valley fever. This is a step
to ensure food security in the region. The COVID-19 pandemic has taught countries well about
getting prepared for diseases that can take the shape of an epidemic. This also
opened avenues that boosts a proper reading of bacterial or fungal diseases
that can turn fatal and spread easily. In fact, the decision of the Chinese
government to make their people aware about the situation in Arizona affirms
this condition. |